Weight gain in insulin‐treated patients by body mass index category at treatment initiation: n ew evidence from real‐world data in patients with type 2 diabetes

SK Paul, JE Shaw, O Montvida… - Diabetes, Obesity and …, 2016 - Wiley Online Library
Aims To evaluate, in patients with type 2 diabetes (T2DM) treated with insulin, the extent of
weight gain over 2 years of insulin treatment, and the dynamics of weight gain in relation to …

Comparative effects of randomized second-line therapy for type 2 diabetes on a composite outcome incorporating glycemic control, body weight, and hypoglycemia …

MS Kirkman, M Tripputi, H Krause-Steinrauf… - Diabetes …, 2024 - Am Diabetes Assoc
OBJECTIVE In Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness
Study (GRADE)(5,047 participants, mean follow-up 5.0 years), differences in glycemic …

Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes

PM O'Neil, K Miller‐Kovach, PW Tuerk, LE Becker… - …, 2016 - Wiley Online Library
Objective Modest weight loss from clinical interventions improves glycemic control in type 2
diabetes (T2DM). Data are sparse on the effects of weight loss via commercial weight loss …

Weight management in type 2 diabetes mellitus

AT Siram, R Yanagisawa… - Mount Sinai Journal of …, 2010 - Wiley Online Library
Obesity is a well known risk factor for type 2 diabetes mellitus. Individuals with type 2
diabetes mellitus are at risk for weight gain as a result of multiple influences, including …

Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with …

WH Herman, Q Pan, SL Edelstein, KJ Mather… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE Both lifestyle and metformin interventions can delay or prevent progression to
type 2 diabetes mellitus (DM) in people with impaired glucose regulation, but there is …

Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially …

AJ Palmer, S Roze, WJ Valentine… - … medical research and …, 2004 - Taylor & Francis
Objective: Weight gain is an unwanted side effect of improved glycaemic control in type 1
diabetes, associated with increased blood pressure (BP) and worsening lipid profiles. While …

Pharmacologic induction of weight loss to treat type 2 diabetes.

JB Redmon, SK Raatz, CA Kwong, JE Swanson… - Diabetes …, 1999 - Am Diabetes Assoc
OBJECTIVE: Most individuals with type 2 diabetes are overweight, and weight loss for them
is an important therapeutic objective. However, usual weight-loss strategies have generally …

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial

MEJ Lean, WS Leslie, AC Barnes… - The lancet Diabetes & …, 2019 - thelancet.com
Summary Background The DiRECT trial assessed remission of type 2 diabetes during a
primary care-led weight-management programme. At 1 year, 68 (46%) of 149 intervention …

Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes

RR Wing, R Klein, SE Moss - Diabetes care, 1990 - Am Diabetes Assoc
Previous studies have suggested that weight gain is an identifiable risk of efforts to lower
blood glucose with intensive insulin therapy in type I (insulin-dependent) diabetic subjects …

[HTML][HTML] Predictors of long term weight loss maintenance in patients at high risk of type 2 diabetes participating in a lifestyle intervention program in primary health care …

A Gilis-Januszewska, NC Barengo, J Lindström… - PloS one, 2018 - journals.plos.org
Lifestyle interventions in type 2 diabetes (DM2) prevention implementation studies can be
effective and lasting. Long-term weight loss maintenance enhances the intervention effect …